Overview

To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia

Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
Prevention of COVID-19 infection to severe pneumonea or ARDS
Phase:
Phase 2
Details
Lead Sponsor:
Enzychem Lifesciences Corporation